+86-13031714605
info@millionpharm.com

  • Company
    • About us

    • Partners

    • Value

    • Careers

  • Product
    • Pharmaceutical API

    • Advanced Intermediate

  • R&D&Site
  • News&Events
  • Sustainability
  • Contact Us

PRODUCTS


Home > Products > Advanced Intermediates
  • 91-8;ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
    91-8;ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
  • 07-4;ethyl 6-(4-aMinophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
    07-4;ethyl 6-(4-aMinophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
  • 91-3;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester
    91-3;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester
  • 44-1;3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one
    44-1;3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one
  • 26-3;1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone
    26-3;1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone
  • 03-0;3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
    03-0;3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
  • 29-9;3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
    29-9;3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
  • 01-2;3,3-Dichloro-1-(4-nitrophenyl)piperidin-2-one
    01-2;3,3-Dichloro-1-(4-nitrophenyl)piperidin-2-one
  • 07-3; Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate
    07-3; Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate
  • 63-8;Ethyl (2Z)-chloro[(4-methoxyphenyl)hydrazono]ethanoate
    63-8;Ethyl (2Z)-chloro[(4-methoxyphenyl)hydrazono]ethanoate
  • <Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next>
  • 

    Cerebro-cardiovascular

  • 

    Central nervous system

  • 

    Cancer/tumor

  • 

    Anti-diabetics

  • 

    R&D&Pipeline

  • 

    Other APIS

  • 

    Peptides

  • 

    Supplements

  • 

    Sexual Enhancement

  • 

    Apixabn intermediates

  • 

    Bexagliflozin Intermediate

  • 

    Lurasidon intermediates

  • 

    Vortioxeti intermediates

  • 

    Selpercatinib intermediates

  • 

    Indacater intermediates

  • 

    Elacestrant intermediates

  • 

    Repotrectinib/TPX-0005 intermediate

  • 

    Baricitinib Intermediate

  • 

    Ropsacitinib intermediate

  • 

    Other intermediates

WELCOME

+86-13031714605
info@millionpharm.com
+86-13031714605

Products

  • Pharmaceutical API

    • Cerebro-cardiovascular

    • Central nervous system

    • Cancer/tumor

    • Anti-diabetics

    • R&D&Pipeline

    • Other APIS

  • Advanced Intermediates

  • Company

    • About us

    • Partners

    • Value

    • Careers

  • R&D&Site

  • News&Events

  • Sustainability

Contact Us

Jinan Million Pharmaceutical Co., Ltd

(Jinan Milin Pharmaceutical Co., Ltd)

+86-13031714605 (Wechat)
+86-13031714605
+86-531-68659554
info@millionpharm.com
Room1-2208, Gaoxin district, Jinan, Shandong
 3299907431

Attention: All products are only for research

© million | All Rights Reserved

Leave A Message

If you are interested in our products and want to know more details, please leave a message here, we will reply you as soon as we can.

SUBMIT


+86-13031714605

WhatsApp

Email

Inquiry
